Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?
Oscar A Fernández-GarcíaCristina HernandezMark RobbinsDima KabbaniKaren E DoucetteCarlos CerveraPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2024)
In this cohort, undergoing SAP tissue invasive disease was uncommon and CMV DNAemia recurrence did not have an impact on long-term mortality.